賽輪輪胎(601058.SH):子公司賽輪董家口擬吸收合併賽輪新材料
格隆匯9月23日丨賽輪輪胎(601058.SH)公佈,董事會同意公司全資子公司青島賽輪輪胎有限公司(簡稱“賽輪董家口”)吸收合併青島賽輪新材料有限公司(簡稱“賽輪新材料”)。合併完成後,賽輪新材料的業務、資產、負債、其他一切權利及義務等均由賽輪董家口承繼,公司“青島董家口年產50萬噸功能化新材料(一期20萬噸)項目”(簡稱“董家口新材料項目”)的實施主體將由賽輪新材料變更為賽輪董家口,該項目擬進行的建設內容、投資金額沒有發生變化。公司董事會授權管理層根據法律法規要求辦理本次吸收合併涉及的資產移交、權屬變更登記、通知債權人、税務和工商變更登記以及法律法規規定的其他程序等具體事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.